According to StarBase (http://starbase.sysu.edu.cn/), MIR17HG has a highly linked potential binding to miR-454-3p, and FAM135A has a putative binding site for miR-454-3p, indicating that MIR17HG may influence FAM135A expression in breast cancer cells. Here, MIR17HG is linked to breast carcinoma.